文献速递前列腺癌

局部腺体消融与根治性前列腺切除术治疗低中危前列腺癌的肿瘤学与功能学结局对比分析

Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes.
PubMed 文献 · J Urol · 2017-08-18

该研究比较了局部腺体消融与机器人辅助根治性前列腺切除术在低中危前列腺癌患者中的肿瘤学与功能学结局。共分析1,458例患者(根治术1,222例,消融236例),倾向评分匹配后比较472例根治术患者与236例消融患者。结果显示局部腺体消融失败率28.8%,挽救治疗风险更高(HR 6.06,p<0.001),但术后控尿恢复和勃起功能更好。

要点

  • 局部腺体消融失败率28.8%,挽救治疗风险显著高于根治术(HR 6.06,p<0.001)。
  • 根治术组术后3、6、12个月控尿恢复和勃起功能均低于消融组(p<0.001)。
  • 两组并发症发生率相当(p=0.06),消融组患者年龄更大(p<0.001)。

核心结论

  • 在选择的器官局限性前列腺癌患者中,局部腺体消融提供了良好的肿瘤控制,且需要额外治疗的不良反应更少。
  • 局部腺体消融后勃起功能和控尿似乎保留更好。

研究设计与样本

  • 回顾性比较分析,纳入2009年7月至2015年9月期间接受机器人辅助根治性前列腺切除术的1,883例患者和接受局部腺体消融的373例患者。
  • 最终分析1,458例,其中根治术1,222例,局部腺体消融236例(高强度聚焦超声188例,冷冻治疗48例)。
  • 纳入标准为Gleason评分3+3或3+4、临床分期≤T2b、前列腺特异性抗原≤15 ng/dl、单侧病变、预期寿命>10年。
  • 采用倾向评分匹配(1:2)在根治术样本中匹配472例患者进行比较。

主要发现

  • 局部腺体消融失败(治疗后任何阳性对照活检)见于68例(28.8%),其中高强度聚焦超声组53例(28.1%),冷冻治疗组15例(31.2%)。
  • 局部腺体消融与更高的挽救治疗风险相关(HR 6.06,p<0.001)。
  • 两组并发症发生率相当(p=0.06)。
  • 机器人辅助根治性前列腺切除术与术后3、6、12个月更少的控尿恢复和更低的勃起功能率相关(p<0.001)。
  • 匹配后两组均衡,但局部腺体消融组患者年龄更大(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We analyzed the oncologic and functional outcomes of partial gland ablation compared with robot-assisted radical prostatectomy in patients with low and intermediate risk prostate cancer. MATERIALS AND METHODS: A total of 1,883 patients underwent robot-assisted radical prostatectomy and 373 underwent partial gland ablation from July 2009 to September 2015. We selected 1,458 of these participants for analysis, including 1,222 and 236 treated with robot-assisted radical prostatectomy and partial gland ablation, respectively. Patients had a Gleason score of 3 + 3 or 3 + 4, clinical stage T2b or less, prostate specific antigen 15 ng/dl or less, unilateral disease and life expectancy greater than 10 years. Propensity score matching analysis (1:2) was applied in the overall robot-assisted radical prostatectomy sample, which selected 472 patients for comparison. For partial gland ablation 188 men underwent high intensity focused ultrasound and 48 underwent cryotherapy. Oncologic outcomes were analyzed in terms of the need for salvage treatment. Partial gland ablation failure was defined as any positive control biopsy after treatment. Functional outcomes were assessed by validated questionnaires. RESULTS: Matching was successful across the 2 groups, although men treated with partial gland ablation were older (p <0.001). Mean followup in the partial gland ablation group was 38.44 months. Partial gland ablation failure was observed in 68 men (28.8%), including 53 (28.1%) treated with high intensity focused ultrasound and 15 (31.2%) treated with cryotherapy. Partial gland ablation was associated with a higher risk of salvage treatment (HR 6.06, p <0.001). Complications were comparable between the groups (p = 0.06). Robot-assisted radical prostatectomy was associated with less continence recovery and a lower potency rate 3, 6 and 12 months after surgery (p <0.001). CONCLUSIONS: In select patients with organ confined prostate cancer partial gland ablation offered good oncologic control with fewer adverse effects that required additional treatments. Potency and continence appeared to be better preserved after partial gland ablation.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Garcia-Barreras S, Sanchez-Salas R, Sivaraman A, et al. Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes. J Urol. 2017. PMID: 28823768. doi:10.1016/j.juro.2017.08.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。